Literature DB >> 21073315

Protein export systems of Mycobacterium tuberculosis: novel targets for drug development?

Meghan E Feltcher1, Jonathan Tabb Sullivan, Miriam Braunstein.   

Abstract

Protein export is essential in all bacteria and many bacterial pathogens depend on specialized protein export systems for virulence. In Mycobacterium tuberculosis, the etiological agent of the disease tuberculosis, the conserved general secretion (Sec) and twin-arginine translocation (Tat) pathways perform the bulk of protein export and are both essential. M. tuberculosis also has specialized export pathways that transport specific subsets of proteins. One such pathway is the accessory SecA2 system, which is important for M. tuberculosis virulence. There are also specialized ESX export systems that function in virulence (ESX-1) or essential physiologic processes (ESX-3). The increasing prevalence of drug-resistant M. tuberculosis strains makes the development of novel drugs for tuberculosis an urgent priority. In this article, we discuss our current understanding of the protein export systems of M. tuberculosis and consider the potential of these pathways to be novel targets for tuberculosis drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073315      PMCID: PMC3034451          DOI: 10.2217/fmb.10.112

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  118 in total

1.  How many potentially secreted proteins are contained in a bacterial genome?

Authors:  G Schneider
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

2.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

3.  The twin arginine consensus motif of Tat signal peptides is involved in Sec-independent protein targeting in Escherichia coli.

Authors:  N R Stanley; T Palmer; B C Berks
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

4.  Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system.

Authors:  L E Alksne; P Burgio; W Hu; B Feld; M P Singh; M Tuckman; P J Petersen; P Labthavikul; M McGlynn; L Barbieri; L McDonald; P Bradford; R G Dushin; D Rothstein; S J Projan
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 5.  Inhibitors of bacterial signal peptidases.

Authors:  M T Black; G Bruton
Journal:  Curr Pharm Des       Date:  1998-04       Impact factor: 3.116

6.  CJ-21,058, a new SecA inhibitor isolated from a fungus.

Authors:  Yutaka Sugie; Sae Inagaki; Yoshinao Kato; Hiroyuki Nishida; Chang-Hong Pang; Toshiyuki Saito; Shinichi Sakemi; Fadia Dib-Hajj; John P Mueller; Joyce Sutcliffe; Yasuhiro Kojima
Journal:  J Antibiot (Tokyo)       Date:  2002-01       Impact factor: 2.649

7.  Comprehensive identification of conditionally essential genes in mycobacteria.

Authors:  C M Sassetti; D H Boyd; E J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 8.  Type III secretion machines: bacterial devices for protein delivery into host cells.

Authors:  J E Galán; A Collmer
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

9.  Two nonredundant SecA homologues function in mycobacteria.

Authors:  M Braunstein; A M Brown; S Kurtz; W R Jacobs
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

10.  The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target.

Authors:  M Paetzel; R E Dalbey; N C Strynadka
Journal:  Pharmacol Ther       Date:  2000-07       Impact factor: 12.310

View more
  41 in total

1.  ADP-dependent conformational changes distinguish Mycobacterium tuberculosis SecA2 from SecA1.

Authors:  Nadia G D'Lima; Carolyn M Teschke
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

2.  Bacterial Protein Reshapes Host Defense toward Antiviral Responses.

Authors:  Hyungjin Eoh; Jae U Jung
Journal:  Mol Cell       Date:  2018-08-16       Impact factor: 17.970

3.  Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions.

Authors:  J Ollinger; T O'Malley; J Ahn; J Odingo; T Parish
Journal:  J Bacteriol       Date:  2012-03-16       Impact factor: 3.490

4.  The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages.

Authors:  Jonathan Tabb Sullivan; Ellen F Young; Jessica R McCann; Miriam Braunstein
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

Review 5.  The ins and outs of Mycobacterium tuberculosis protein export.

Authors:  Lauren S Ligon; Jennifer D Hayden; Miriam Braunstein
Journal:  Tuberculosis (Edinb)       Date:  2011-12-21       Impact factor: 3.131

6.  Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.

Authors:  Shawn I Walsh; Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem       Date:  2016-09-21       Impact factor: 3.641

7.  The twin arginine translocation system is essential for aerobic growth and full virulence of Burkholderia thailandensis.

Authors:  Sariqa Wagley; Claudia Hemsley; Rachael Thomas; Madeleine G Moule; Muthita Vanaporn; Clio Andreae; Matthew Robinson; Stan Goldman; Brendan W Wren; Clive S Butler; Richard W Titball
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

Review 8.  ESX secretion systems: mycobacterial evolution to counter host immunity.

Authors:  Matthias I Gröschel; Fadel Sayes; Roxane Simeone; Laleh Majlessi; Roland Brosch
Journal:  Nat Rev Microbiol       Date:  2016-09-26       Impact factor: 60.633

Review 9.  Bacterial pathogens commandeer Rab GTPases to establish intracellular niches.

Authors:  Mary-Pat Stein; Matthias P Müller; Angela Wandinger-Ness
Journal:  Traffic       Date:  2012-09-13       Impact factor: 6.215

10.  Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease.

Authors:  Mykhaylo S Frasinyuk; Stefan Kwiatkowski; Jonathan M Wagner; Timothy J Evans; Robert W Reed; Konstantin V Korotkov; David S Watt
Journal:  Bioorg Med Chem Lett       Date:  2014-05-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.